ATC:A10BB09

Name Dosage Analogs / Brand Names
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)ureadosageGliclazide; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)ureadosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; Gliclazide; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Diamicrondosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Gliclazide; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Gliclazida [INN-Spanish]dosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazide; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
GliclazideTablet1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Gliclazide (JAN)dosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide; Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Gliclazide [BAN:DCF:INN:JAN]dosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Gliclazidum [INN-Latin]dosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazide; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Glimicrondosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Gliclazide; Gliclazide (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
Glimicron (TN)dosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Gliclazide; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Nordialex
N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)ureadosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); Gliclazide; Nordialex
Nordialexdosage1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diamicron; Gliclazida [INN-Spanish]; Gliclazide (JAN); Gliclazide [BAN:DCF:INN:JAN]; Gliclazidum [INN-Latin]; Glimicron; Glimicron (TN); N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Gliclazide